Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
about
Development of Human Membrane Transporters: Drug Disposition and PharmacogeneticsQualitative de novo analysis of full length cDNA and quantitative analysis of gene expression for common marmoset (Callithrix jacchus) transcriptomes using parallel long-read technology and short-read sequencingCyanobacterial Toxins of the Laurentian Great Lakes, Their Toxicological Effects, and Numerical Limits in Drinking WaterOntogeny of human hepatic and intestinal transporter gene expression during childhood: age matters.Frequencies of two functionally significant SNPs and their haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in six ethnic groups of Pakistani population.Mechanisms and assessment of statin-related muscular adverse effects.Histogram analysis of gadoxetic acid-enhanced MRI for quantitative hepatic fibrosis measurementA semi-physiologically based pharmacokinetic pharmacodynamic model for glycyrrhizin-induced pseudoaldosteronism and prediction of the dose limit causing hypokalemia in a virtual elderly population.Zebrafish Oatp-mediated transport of microcystin congeners.OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapyABCB1 polymorphism is associated with atorvastatin-induced liver injury in Japanese population.Determinants of post-prandial plasma bile acid kinetics in human volunteers.Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis.Inherited variation in OATP1B1 is associated with treatment outcome in acute myeloid leukemia.Expression Patterns of Organic Anion Transporting Polypeptides 1B1 and 1B3 Protein in Human Pediatric LiverFunctional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2Abundance of Hepatic Transporters in Caucasians: A Meta-Analysis.More Power to OATP1B1: An Evaluation of Sample Size in Pharmacogenetic Studies Using a Rosuvastatin PBPK Model for Intestinal, Hepatic, and Renal Transporter-Mediated Clearances.Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sexThe regulation of human hepatic drug transporter expression by activation of xenobiotic-sensing nuclear receptors.Current status and recent advances of next generation sequencing techniques in immunological repertoire.Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546M as functionally damaging variant.Impact of Transporter Polymorphisms on Drug Development: Is It Clinically Significant?Resveratrol and its major sulfated conjugates are substrates of organic anion transporting polypeptides (OATPs): impact on growth of ZR-75-1 breast cancer cells.Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1).Chinese biobanks: present and future.Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.Ecological population genomics in the marine environment.Heritability of metoprolol and torsemide pharmacokinetics.Toward Prospective Prediction of Pharmacokinetics in OATP1B1 Genetic Variant Populations.Identification of the effect of multiple polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid using a population-modeling approach.Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer.Identification of two novel genes SLC15A2 and SLCO1B3 associated with maintenance dose variability of warfarin in a Chinese population.Effect modification by region in the associations of LEP G2548A and LEPR Q223R polymorphisms with statin-induced CK elevation.Transporter expression in non-cancerous and cancerous liver tissue from donors with hepatocellular carcinoma and chronic hepatitis C infection quantified by LC-MS/MS proteomics.Inter-Subject Variability in OCT1 Activity in 27 Batches of Cryopreserved Human Hepatocytes and Association with OCT1 mRNA Expression and Genotype.Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics.Reproductive management through integration of PGD and MPS-based noninvasive prenatal screening/diagnosis for a family with GJB2-associated hearing impairment.SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case-control study.Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2.
P2860
Q26786582-E537B32B-42E8-40BA-BCFB-00C37092E8A4Q28540182-1FA2CC35-551D-46F0-B0DD-3B878FC9B760Q33833344-760CADB2-3407-4B1E-85B1-4931224EA8ADQ33942993-8E9F3696-3393-4CD5-A6C3-6FCE1F569C36Q34065757-3128FBE2-F0B8-42A4-9825-2AA58E5BD084Q34570995-F1884F7C-39DD-4DE0-897D-17916CA37369Q34612486-0A327E15-73A3-45A5-8F9C-B79C4D9B6D2FQ35478170-B178D5DC-850E-48D7-BA63-7D76EB9410FFQ35657461-26D3BE9A-09A8-42F3-9402-D092A74684D1Q35678729-C15269D0-0856-48AE-A75A-A9C499D0D72CQ36050960-C56F0C92-E0B2-463C-9896-6A252DF9D235Q36414100-553F77C5-4881-4169-8938-4EAAB1F39424Q36439164-832EEA06-77C4-48D3-9BDF-C264ADEFFF2EQ36981855-AD053F15-B967-4E7B-813B-39186C70AC2AQ37062634-561A4186-6BE2-4D18-81B4-8621813A7928Q37207831-467408D1-9217-471E-B20A-514FD8D11792Q37279044-51630344-AA0D-413C-97AE-51F7D1A02412Q37394474-3B463EBD-7A30-4372-BBFB-5A72A810E517Q37422685-527C061C-49BB-4551-AB67-23E4AD5F02C2Q38750759-78844EA2-8539-42AB-9CAA-8BBEC2053646Q38768307-35E3A303-EEDB-44F5-8969-238D5F111FEDQ38884180-7BD10BF6-D661-46C5-A292-8536CA459584Q38888369-77EE72C3-81FE-424C-B04F-026AC6B6FDEAQ38977944-44385AF5-4428-48EC-B8F0-CAAC852FA33AQ39034284-B5557160-6453-4029-9E8D-2E1516E859C5Q39231340-677D8564-DBDE-4699-A187-125778A9913FQ39683666-9553FA49-F946-4CFF-95A0-1991C8553FD0Q39864227-8731078B-BCC4-44BD-B001-969F6A54812BQ41398712-33B46066-6B3B-4A4E-BFAF-FB8D00E411B3Q41706349-0BF2911D-F431-401D-9563-2B5DA18507C6Q43965937-87313337-BF1C-49EC-9E3F-A13AEF7CC5EDQ45988129-2C44E1B9-0285-4ECD-A97B-859B62898AD4Q47113473-ECAB6ACE-A732-4B64-842F-FB8071578013Q47342360-2892F220-F3EE-49EB-8F08-35573708B7A4Q47402203-DE9237F9-ED1F-4448-ACA1-26564FE75AF2Q47808595-7A3E1813-FE01-471A-A896-4D565A68EE16Q49903283-3495D5E8-5717-4495-BB3C-C0808E3523FDQ50351727-FA8D0272-F050-4A7A-9712-A7F0D2B2F691Q53099880-1755B132-D842-4FDF-AFE0-2C1098EA4FEDQ54373168-418CEC0C-E974-4774-9EC0-B81E01C59FCB
P2860
Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Genetics is a major determinan ...... but not of OATP1B3 and OATP2B1
@en
type
label
Genetics is a major determinan ...... but not of OATP1B3 and OATP2B1
@en
prefLabel
Genetics is a major determinan ...... but not of OATP1B3 and OATP2B1
@en
P2093
P2860
P356
P1433
P1476
Genetics is a major determinan ...... but not of OATP1B3 and OATP2B1
@en
P2093
Anne T Nies
Bruno Stieger
Matthias Schwab
Mikko Niemi
Oliver Burk
Stefan Winter
P2860
P2888
P356
10.1186/GM405
P577
2013-01-11T00:00:00Z
P5875
P6179
1042062406